Article

Mississippi to reimburse for TTT of wet AMD

Mountain View, CA-Add Mississippi to the list of states whose Medicare administrators will pay for transpupillary thermother-apy (TTT) treatment of wet age-related macular degeneration (AMD).

Related Videos
Image credit: Ophthalmology Times; Dean McGee Eye Institute resident Ashley Ooms, MD, explores gray area strabismus surgery complications in AUPO poster
Vicki Chan, MD, shares pearls for leveraging the power of social media in health care
Related Content
(Image credit: AdobeStock/iQoncept)
March 26th 2025

Beyond mentoring: The power of sponsorship and advocacy in ophthalmology

Commercial real estate and your practice, part two with Colin Carr
May 21st 2022

Commercial real estate and your practice, part two with Colin Carr

How COVID-19 shifted ophthalmologist-patient communication
March 21st 2025

How COVID-19 shifted ophthalmologist-patient communication

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)
May 12th 2022

Tips, tricks, what to dos and what not to dos on how you can save money as a healthcare provider on your commercial real estate (Part 1)

FDA accepts new drug application for low-dose atropine from Sydnexis
March 11th 2025

FDA accepts new drug application for low-dose atropine from Sydnexis

The search for an antifibrotic drug for use with pediatric glaucoma devices
March 5th 2025

The search for an antifibrotic drug for use with pediatric glaucoma devices

© 2025 MJH Life Sciences

All rights reserved.